EQUASENS (EQS.PA) Stock Fundamental Analysis
Europe - EPA:EQS - FR0012882389 - Common Stock
40.8 EUR
-0.55 (-1.33%)
We assign a fundamental rating of 6 out of 10 to EQS. EQS was compared to 11 industry peers in the Health Care Technology industry. While EQS has a great profitability rating, there are some minor concerns on its financial health. EQS has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year EQS was profitable.
In the past year EQS had a positive cash flow from operations.
EQS had positive earnings in each of the past 5 years.
EQS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 8.84%, EQS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
EQS has a Return On Equity of 15.79%. This is amongst the best in the industry. EQS outperforms 81.82% of its industry peers.
The Return On Invested Capital of EQS (12.70%) is better than 90.91% of its industry peers.
EQS had an Average Return On Invested Capital over the past 3 years of 15.18%. This is significantly above the industry average of 9.03%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROIC | 12.7% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
With an excellent Profit Margin value of 16.15%, EQS belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
In the last couple of years the Profit Margin of EQS has remained more or less at the same level.
Looking at the Operating Margin, with a value of 19.80%, EQS belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Operating Margin of EQS has declined.
EQS has a Gross Margin of 68.81%. This is in the lower half of the industry: EQS underperforms 63.64% of its industry peers.
In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
EQS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
EQS has about the same amout of shares outstanding than it did 1 year ago.
EQS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EQS has an improved debt to assets ratio.
2.2 Solvency
EQS has an Altman-Z score of 3.90. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.90, EQS is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
EQS has a debt to FCF ratio of 0.98. This is a very positive value and a sign of high solvency as it would only need 0.98 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.98, EQS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
A Debt/Equity ratio of 0.09 indicates that EQS is not too dependend on debt financing.
EQS's Debt to Equity ratio of 0.09 is fine compared to the rest of the industry. EQS outperforms 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Altman-Z | 3.9 |
ROIC/WACC1.64
WACC7.73%
2.3 Liquidity
A Current Ratio of 1.29 indicates that EQS should not have too much problems paying its short term obligations.
EQS has a Current ratio of 1.29. This is comparable to the rest of the industry: EQS outperforms 45.45% of its industry peers.
A Quick Ratio of 1.20 indicates that EQS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.20, EQS is in line with its industry, outperforming 45.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.07%.
EQS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.12% yearly.
The Revenue has been growing slightly by 4.45% in the past year.
Measured over the past years, EQS shows a small growth in Revenue. The Revenue has been growing by 6.45% on average per year.
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
3.2 Future
Based on estimates for the next years, EQS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.63% on average per year.
EQS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.74% yearly.
EPS Next Y18.72%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.07 indicates a rather expensive valuation of EQS.
Compared to the rest of the industry, the Price/Earnings ratio of EQS indicates a rather cheap valuation: EQS is cheaper than 81.82% of the companies listed in the same industry.
EQS is valuated rather cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
EQS is valuated correctly with a Price/Forward Earnings ratio of 12.56.
81.82% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (22.85), we can say EQS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.07 | ||
| Fwd PE | 12.56 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EQS indicates a rather cheap valuation: EQS is cheaper than 81.82% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.67 | ||
| EV/EBITDA | 8.52 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EQS may justify a higher PE ratio.
A more expensive valuation may be justified as EQS's earnings are expected to grow with 18.63% in the coming years.
PEG (NY)0.91
PEG (5Y)3.33
EPS Next 2Y19.01%
EPS Next 3Y18.63%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.11%, EQS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.42, EQS pays a bit more dividend than its industry peers.
EQS's Dividend Yield is a higher than the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
5.2 History
The dividend of EQS is nicely growing with an annual growth rate of 8.00%!
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
51.75% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.75%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPA:EQS (10/17/2025, 5:29:54 PM)
40.8
-0.55 (-1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.62%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap618.94M
Analysts80
Price Target50.49 (23.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.75%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.07 | ||
| Fwd PE | 12.56 | ||
| P/S | 2.75 | ||
| P/FCF | 16.67 | ||
| P/OCF | 12.83 | ||
| P/B | 2.69 | ||
| P/tB | 7.75 | ||
| EV/EBITDA | 8.52 |
EPS(TTM)2.39
EY5.86%
EPS(NY)3.25
Fwd EY7.96%
FCF(TTM)2.45
FCFY6%
OCF(TTM)3.18
OCFY7.8%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)0.91
PEG (5Y)3.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROCE | 15.59% | ||
| ROIC | 12.7% | ||
| ROICexc | 17.92% | ||
| ROICexgc | 69.44% | ||
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% | ||
| FCFM | 16.53% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexcg growth 3Y-25.09%
ROICexcg growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 69.34% | ||
| Cap/Sales | 4.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.71% | ||
| Profit Quality | 102.29% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 3.9 |
F-Score7
WACC7.73%
ROIC/WACC1.64
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y18.72%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-8.02%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year59.12%
EBIT Next 3Y27.46%
EBIT Next 5YN/A
FCF growth 1Y-36.73%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-31.7%
OCF growth 3Y0.02%
OCF growth 5Y3.18%